NanoVibronix extends distribution pact with largest distributor UPPI, secures purchase guarantees through 2023

ENvue Medical, Inc.

Extends exclusive distribution of PainShield and PainShield Plus to UPPI for DME sector in the US.
Immediate re-stocking order and minimum purchase guarantees through end of 2023.
Term runs 12 months or until CMS assigns reimbursement value, whichever comes first.
CMS application submitted March 2023; reimbursements could start as early as October 1, 2023 if approved.
UPPI is NanoVibronix's largest PainShield distributor.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

ENvue Medical, Inc. amended Amended and Restated Distribution Agreement for private labeled products with Ultra Pain Products Inc. valued at Amendment to exclusive distribution agreement for PainShield and PainShield Plus devices; includes r (effective 2023-08-11).

Action: amendment
Agreement: supply
Counterparty: Ultra Pain Products Inc.
Value: Amendment to exclusive distribution agreement for PainShield and PainShield Plus devices; includes r
Effective: 2023-08-11

Exact text from the filing

On August 22, 2023, NanoVibronix, Inc. (the “ Company ”), entered into a second amendment (the “Amendment”) to the Amended and Restated Distribution Agreement for private labeled products, dated December 10, 2020 (as amended by the Amendment, the “ Agreement ”), between the Company and Ultra Pain Products Inc. (“ UPPI ”), effective as of August 11, 2023.

View on SEC.gov

280 material agreements filed in the last 30 days. Browse all material agreements →

ENvue Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-029969

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.